Stocktoria
INTELLIGENT BIO SOLUTIONS INC. INBS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-12-23
INTELLIGENT BIO SOLUTIONS INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 40.8% | 45.8% | 26.0% | — | — |
| Operating margin | -348.7% | -330.5% | -1002.1% | -1907.1% | -281.4% |
| Net margin | -346.2% | -326.4% | -845.9% | -1900.1% | -355.3% |
| FCF margin | -324.6% | -314.7% | — | — | — |
| Return on assets | -128.1% | -73.7% | -102.7% | -67.2% | -32.2% |
| Return on equity | -352.7% | -121.9% | -279.9% | -125.4% | -46.7% |
| Current ratio | 0.77 | 1.57 | 0.66 | 2.33 | 4.94 |
| Revenue growth | -1.9% | 147.6% | 187.5% | -77.9% | 949.3% |
Source: SEC EDGAR filings · CIK 0001725430 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.